Oncogene-induced senescence as an initial barrier in lymphoma development
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Acute induction of oncogenic Ras provokes cellular senescence involving the retinoblastoma (Rb) pathway, but the tumour suppressive potential of senescence in vivo remains elusive. Recently, Rb-mediated silencing of growth-promoting genes by heterochromatin formation associated with methylation of histone H3 lysine 9 (H3K9me) was identified as a critical feature of cellular senescence, which may depend on the histone methyltransferase Suv39h1. Here we show that Emicro-N-Ras transgenic mice harbouring targeted heterozygous lesions at the Suv39h1, or the p53 locus for comparison, succumb to invasive T-cell lymphomas that lack expression of Suv39h1 or p53, respectively. By contrast, most N-Ras-transgenic wild-type ('control') animals develop a non-lymphoid neoplasia significantly later. Proliferation of primary lymphocytes is directly stalled by a Suv39h1-dependent, H3K9me-related senescent growth arrest in response to oncogenic Ras, thereby cancelling lymphomagenesis at an initial step. Suv39h1-deficient lymphoma cells grow rapidly but, unlike p53-deficient cells, remain highly susceptible to adriamycin-induced apoptosis. In contrast, only control, but not Suv39h1-deficient or p53-deficient, lymphomas senesce after drug therapy when apoptosis is blocked. These results identify H3K9me-mediated senescence as a novel Suv39h1-dependent tumour suppressor mechanism whose inactivation permits the formation of aggressive but apoptosis-competent lymphomas in response to oncogenic Ras.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [120]
In the citing paper
“Oncogene-induced senescence protects against tumor initiation 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“OIS is a powerful tumor suppressor mechanism 34–37.”
From Cardiac glycosides are broad-spectrum senolytics (2019) · cites this paper as [36]
In the citing paper
“a series of studies [22][23][24][25][26] identified senescence in several premalignant tumours, both in humans and mice.”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
In the citing paper
“| DNA damage | Eμ-Nras G12V ; ectopic Bcl2 | Doxorubicin | Lymphoma regression | 22 | | | |”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [22]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Gene Action in the X-chromosome of the Mouse (Mus musculus L.)
LYON, M. F. (1961) · Nature · doi:10.1038/190372a0 · Cited by 3,978 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Self-citationRegulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“5 with a T(6;15) translocation (see Supplementary Table 3 for details).”
BackgroundSelf-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Self-citationSibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Self-citation
Cited by
Items 601–700 of 1,001
p35 Is Required for CDK5 Activation in Cellular Senescence
Mao, D., & Hinds, P. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066118 · Cited by 44
CPEB Control of NF-κB Nuclear Localization and Interleukin-6 Production Mediates Cellular Senescence
Groppo, R., & Richter, J. D. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05133-11 · Cited by 39
Advances in melanoma senescence and potential clinical application
Giuliano, S., Ohanna, M., Ballotti, R., & Bertolotto, C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2010.00820.x · Cited by 47
Senescence and pre-malignancy: How do tumors progress?
Saab, R. H. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.013 · Cited by 42
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
Saleh, T., Alhesa, A., Al-Balas, M., Abuelaish, O. M., Mansour, A. T., Awad, H., El‐Sadoni, M., Carpenter, V. J., & Azab, B. (2021) · Bioscience Reports · doi:10.1042/bsr20210079 · Cited by 40
Remodeling chromatin for senescence.
Adams, P. D. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00313.x · Cited by 37
Pare, R., Shin, J., & Lee, C. S. (2016) · Histopathology · doi:10.1111/his.12948 · Cited by 37
“By entering either one of the pathways, cancer cells may be directed to senescence, and cancer progression may be inhibited, as has been demonstrated by many in-vivo and in-vitro studies.(13,14) Induction of either p53 or p16 in response to abnormal mitogenic signalling promotes premature senescence, suggesting that i…”
BackgroundSenescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 45
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
Fakhri, S., Moradi, S. Z., Ash-Rafzadeh, A., & Bishayee, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105961 · Cited by 39
Role of Peritoneal Mesothelial Cells in the Progression of Peritoneal Metastases
Li, J., & Guo, T. (2022) · Cancers · doi:10.3390/cancers14122856 · Cited by 39
Martínez, A. B., LÓPEZ-DURÁN, M., Cano‐Sánchez, J., Sánchez-Verde, L., DÍEZ-RODRÍGUEZ, A., AGUIRRE-ECHEBARRÍA, P., Álvarez‐Fernández, E., González‐Moles, M. Á., Bascones-Ilundáin, J., Muzio, L. L., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.649 · Cited by 37
Hepatitis B virus X protein overcomes oncogenic RAS‐induced senescence in human immortalized cells
Oishi, N., Shilagardi, K., Nakamoto, Y., Honda, M., Kaneko, S., & Murakami, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00579.x · Cited by 37
A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest
Angus, S. P., & Nevins, J. R. (2012) · Oncogene · doi:10.1038/onc.2011.622 · Cited by 36
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Hsu, C.-C., Lee, Y., Yeh, S.-H., Chen, C.-H., Wu, C., Wang, T., Chen, Y.-N., Hung, L., Liu, Y.-W., Chen, H.-K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.335331 · Cited by 39
DNA damage response in adult stem cells
Insinga, A., Cicalese, A., & Pelicci, P. G. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.12.005 · Cited by 41
Lee, S.-J., Lee, S.-H., Yoon, M.-H., & Park, B.-J. (2013) · Neoplasia · doi:10.1593/neo.121862 · Cited by 38
Self-citationUBTD1 induces cellular senescence through an UBTD1 –Mdm2/p53 positive feedback loop
Zhang, X.-W., Wang, X., Ni, S.-J., Qin, W., Zhao, L.-Q., Hua, R., Lu, Y.-W., Li, J., Dimri, G. P., & Guo, W. (2015) · The Journal of Pathology · doi:10.1002/path.4478 · Cited by 38
Nuclear JAK2: Form and Function in Cancer
Qian, C., Yao, J., & Si, J. (2011) · The Anatomical Record · doi:10.1002/ar.21443 · Cited by 36
Braig, M., Pällmann, N., Preukschas, M., Steinemann, D., Hofmann, W. A., Gompf, A., Streichert, T., Braunschweig, T. A., Copland, M., Rudolph, K. L., et al. (2014) · Leukemia · doi:10.1038/leu.2014.95 · Cited by 37
Self-citationZhang, Y., Cheng, Y., Ren, X., Hori, T., Huber-Keener, K. J., Zhang, L., Yap, K. L., Liu, D., Shantz, L. M., Qin, Z.-H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0139 · Cited by 41
Johnson, T. M., Meade, K., Pathak, N., Marques, M. R., & Attardi, L. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706764105 · Cited by 35
Inverse relationship between genetic diversity and epigenetic complexityPreprint
Huang, S. (2009) · Nature Precedings · doi:10.1038/npre.2009.1751.2 · Cited by 39
H3K9me3-mediated epigenetic regulation of senescence in mice predicts outcome of lymphoma patients
Schleich, K., Kase, J., Dörr, J. R., Trescher, S., Bhattacharya, A., Yu, Y., Wailes, E. M., Fan, D. N. Y., Lohneis, P., Milanovic, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17467-z · Cited by 32
Self-citationMamun, A. A., Sufian, M. A., Uddin, M. S., Sumsuzzman, D. M., Jeandet, P., Islam, M. S., Zhang, H., Kong, A. T., & Sarwar, M. S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174991 · Cited by 41
Ali, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 39
Telomeres and telomerase: Biological and clinical importance in dogs
Nasir, L. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.01.024 · Cited by 42
The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
Kilic Eren, M., & Tabor, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101064 · Cited by 36
Cole, A. M., Ridgway, R. A., Derkits, S. E., Parry, L., Barker, N., Clevers, H., Clarke, A. R., & Sansom, O. J. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000101 · Cited by 37
Chromatin‐modifying proteins in cancer
Fog, C. K., Jensen, K. T., & Lund, A. H. (2007) · Apmis · doi:10.1111/j.1600-0463.2007.apm_776.xml.x · Cited by 37
CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Däbritz, J. H. M., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M. T., Dörr, J. R., Kaufmann, A. M., Dörken, B., & Schmitt, C. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0627 · Cited by 37
Self-citationUpregulation of chicken p15INK4b at senescence and in the developing brain
Kim, S.-H., Rowe, J., Fujii, H., Jones, R., Schmierer, B., Kong, B.-W., Kuchler, K., Foster, D., Ish-Horowicz, D., & Peters, G. (2006) · Journal of Cell Science · doi:10.1242/jcs.02989 · Cited by 31
Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence
Yogev, O., Anzi, S., Inoue, K., & Shaulian, E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602865200 · Cited by 34
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence
Abad, M., Moreno, A., Palacios, A., Narita, M., Blanco, F. J., Moreno‐Bueno, G., Narita, M., & Palmero, I. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00651.x · Cited by 43
The Histone Methyltransferase SUV39H1 Suppresses Embryonal Rhabdomyosarcoma Formation in Zebrafish
Albacker, C. E., Storer, N. Y., Langdon, E. M., DiBiase, A., Zhou, Y., Langenau, D. M., & Zon, L. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064969 · Cited by 36
Bajaj, A., Zheng, Q., Adam, A. P., Vincent, P. A., & Pumiglia, K. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2648 · Cited by 34
Brassat, U., Balabanov, S., Bali, D., Dierlamm, J., Braig, M., Hartmann, U., Sirma, H., Güneş, Ç., Wege, H., Fehse, B., et al. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.10.001 · Cited by 37
Self-citationDissecting cellular senescence and SASP in Drosophila
Ito, T., & Igaki, T. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0031-4 · Cited by 36
Cellular senescence in oral cancer and precancer and treatment implications: A review
Campo, J., Cano‐Sánchez, J., Palacios-Sánchez, B., Llamas-Martínez, S., Muzio, L. L., & Martínez, A. B. (2008) · Acta Oncologica · doi:10.1080/02841860802183612 · Cited by 37
Helleday, T. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.044 · Cited by 35
Tangled fibroblasts in tumor‐stroma interactions
Liu, M., Xu, J., & Deng, H. (2011) · International Journal of Cancer · doi:10.1002/ijc.26116 · Cited by 37
Targeting LINC00673 expression triggers cellular senescence in lung cancer
Roth, A., Boulay, K., Groß, M., Polycarpou‐Schwarz, M., Mallette, F. A., Regnier, M., Bida, O., Ginsberg, D., Warth, A., Schnabel, P. A., et al. (2018) · RNA Biology · doi:10.1080/15476286.2018.1553481 · Cited by 36
Tran, H. T. T., Kim, H. N., Lee, I.-K., Nguyen-Pham, T.-N., Ahn, J., Kim, Y., Lee, J., Park, K.-S., Kook, H., & Kim, H. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.2.237 · Cited by 36
Berman, H. K., Gauthier, M. L., & Tlsty, T. D. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0073 · Cited by 36
The Power Behind the Throne: Senescence and the Hallmarks of Cancer
Hoare, M., & Narita, M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050352 · Cited by 33
Kitajima, S., Miki, T., Takegami, Y., Kido, Y., Noda, M., Hara, E., Shamma, A., & Takahashi, C. (2010) · Oncogene · doi:10.1038/onc.2010.448 · Cited by 37
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
Delestré, L., Cui, H., Esposito, M., Quiveron, C., Mylonas, E., Penard-Lacronique, V., Bischof, O., & Guillouf, C. (2017) · Haematologica · doi:10.3324/haematol.2016.157636 · Cited by 32
“The expression of the hematopoietic oncogenes HRAS, BCR-ABL, CBFBMYH11 or RUNX1-ETO in primary HSCs and committed progenitors (HSCPs) elicits a senescence response,(32) and OIS acts as an antitumoral barrier in NRAS-induced lymphomas and MLL-ENL-induced AML.(33,34) Senescence can be triggered, at least in part, by DNA…”
BackgroundChen, J., Yeh, K., Yang, Y.-M., Chang, J., Lee, H.-E., & Hung, S. (2013) · Medical Oncology · doi:10.1007/s12032-013-0513-z · Cited by 33
p53 and regulation of tumor metabolism
Yang, X., Jiang, P., & Du, W. (2013) · Journal of Carcinogenesis · doi:10.4103/1477-3163.122760 · Cited by 36
Zhu, H., Chan, K. T., Huang, X., Cerra, C., Blake, S., Trigos, A., Anderson, D., Creek, D. J., Souza, D. P. D., Wang, X., et al. (2022) · eLife · doi:10.7554/elife.71929 · Cited by 36
Ma, Y., Lü, B., Ruan, W., Wang, H., Lin, J., Hu, H., Deng, H., Huang, Q., & Lai, M. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.04.005 · Cited by 34
JAK-STAT in heterochromatin and genome stability
Silver-Morse, L., & Li, W. X. (2013) · JAK-STAT · doi:10.4161/jkst.26090 · Cited by 36
Meyer, M., Rübsamen, D., Slany, R. K., Illmer, T., Stabla, K., Roth, P., Stiewe, T., Eilers, M., & Neubauer, A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007768 · Cited by 32
Radiloff, D. R., Wakeman, T. P., Feng, J., Schilling, S. H., Seto, E., & Wang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017269108 · Cited by 32
Yang, H.-S., & Hinds, P. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3141 · Cited by 36
Molecular Mechanisms Underlying Pituitary Pathogenesis
Sapochnik, M., Nieto, L., Fuertes, M., & ARZT, E. S. (2015) · Biochemical Genetics · doi:10.1007/s10528-015-9709-6 · Cited by 33
Beisiegel, M., Kursar, M., Koch, M., Loddenkemper, C., Kuhlmann, S., Zedler, U., Stäber, M., HURWITZ, R. M., & Kaufmann, S. H. E. (2009) · The Journal of Infectious Diseases · doi:10.1086/597421 · Cited by 37
Self-citationIshiguro, N., & Yoshida, H. (2016) · Neoplasia · doi:10.1016/j.neo.2016.08.001 · Cited by 33
Accumulation of senescent cells in the stroma of aged mouse ovary
Maruyama, N., FUKUNAGA, I., Tomoaki, K. O. G. O., Endo, T., Fujii, W., Kanai‐Azuma, M., Naito, K., & Sugiura, K. (2023) · Journal of Reproduction and Development · doi:10.1262/jrd.2023-021 · Cited by 33
Failsafe program escape and EMT: A deleterious partnership
Ansieau, S., Courtois-Cox, S., Morel, A., & Puisieux, A. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.09.014 · Cited by 36
PML links aberrant cytokine signaling and oncogenic stress to cellular senescence
Bourdeau, V. (2009) · Frontiers in Bioscience · doi:10.2741/3256 · Cited by 30
Multiparameter flow cytometric detection and quantification of senescent cells in vitro
Adewoye, A. B., Tampakis, D., Follenzi, A., & Stolzing, A. (2020) · Biogerontology · doi:10.1007/s10522-020-09893-9 · Cited by 33
Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy
Kennedy, A. L., Adams, P. D., & Morton, J. P. (2011) · Small GTPases · doi:10.4161/sgtp.2.5.17367 · Cited by 37
Lipid metabolism dynamics in cancer stem cells: potential targets for cancers
Du, J., & Qin, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1367981 · Cited by 33
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
Chao, S. K., Horwitz, S. B., & McDaid, H. M. (2011) · Oncotarget · doi:10.18632/oncotarget.221 · Cited by 33
Ali, Z., Ganie, S. H., Narula, A., Sharma, M. P., & Srivastava, P. S. (2012) · Industrial Crops and Products · doi:10.1016/j.indcrop.2012.07.070 · Cited by 31
Une re-vue de la sénescence cellulaire: Ami ou ennemi de la promotion tumorale ?
Bischof, O., Dejean, A., & Pineau, P. (2009) · médecine/sciences · doi:10.1051/medsci/2009252153 · Cited by 32
Murakami, S., Noguchi, T., Takeda, K., & Ichijo, H. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00551.x · Cited by 32
Bypassing cellular senescence by genetic screening tools
Vergel, M., & Carnero, A. (2010) · Clinical & Translational Oncology · doi:10.1007/s12094-010-0528-2 · Cited by 32
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
JAK inhibition in PD-1 immunotherapy and tumor microenvironment
Liu, Y., Liu, J., Chu, H., Lu, Z., Xu, S., Qin, Y., Zhao, L., & Zhang, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1790936 · Cited by 34
Dynamic involvement of ATG5 in cellular stress responses
Lin, H., Lin, S.-M., Chung, Y., Vonderfecht, S. L., Camden, J. M., Flodby, P., Borok, Z., Limesand, K. H., Mizushima, N., & Ann, D. K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.428 · Cited by 30
Triptolide inhibits tumor growth by induction of cellular senescence
Li, R., Zhang, X., Tian, X., Shen, C., Zhang, Q., Zhang, Y., Wang, Z., Wang, F., & Tao, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.5258 · Cited by 29
Romero-Masters, J. C., Ohashi, M., Djavadian, R., Eichelberg, M. R., Hayes, M., Bristol, J. A., Ma, S., Ranheim, E. A., Gumperz, J. E., Johannsen, E., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007221 · Cited by 34
Avermectin induced DNA damage to the apoptosis and autophagy in human lung epithelial A549 cells
Diao, L., Tang, N., Zhang, C., Cheng, J., Zhang, Z., Wang, S., Wu, C., Zhang, L., Tao, L., Li, Z., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112129 · Cited by 29
Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics
Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 28
The significance of the senescence pathway in breast cancer progression
Pare, R. B., Yang, T., Shin, J., & Lee, C. S. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201081 · Cited by 34
Cellular Senescence as a Possible Mechanism for Halting Progression of Keloid Lesions
Varmeh, S., Egia, A., McGrouther, D. A., Tahan, S. R., Bayat, A., & Pandolfi, P. P. (2011) · Genes & Cancer · doi:10.1177/1947601912440877 · Cited by 31
Antagonistic TSC22D1 variants control BRAFE600‐induced senescence
Cornelia, H.-H., van Doorn, R., Vogel, C., Germann, M., Cecchini, M. G., Verdegaal, E. M. E., & Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.95 · Cited by 31
c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
Flanagan, K. C., Alspach, E., Pazolli, E., Parajuli, S. P., Ren, Q., Arthur, L., TAPIA-CONYER, R. C., & Stewart, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22940 · Cited by 31
Requirement of RIZ1 for Cancer Prevention by Methyl-Balanced DietPreprint
Zhou, W., Alonso, S., Takai, D., Lu, S. C.-L., Yamamoto, F., Perucho, M., & Huang, S. (2008) · Nature Precedings · doi:10.1371/journal.pone.0003390 · Cited by 31
Oncogene‐induced senescence and melanoma: where do we stand?
Peeper, D. S. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00933.x · Cited by 31
Haraoka, Y., Akieda, Y., Nagai, Y., Mogi, C., & Ishitani, T. (2022) · Nature Communications · doi:10.1038/s41467-022-29061-6 · Cited by 28
Lee, J., Oh, E., Yoo, J. Y., Choi, K. S., Yoon, M. J., & Yun, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3018 · Cited by 28
Oh, J. H., Gertych, A., & Tajbakhsh, J. (2013) · Oncotarget · doi:10.18632/oncotarget.942 · Cited by 30
Epigenetics and senescence: Learning from the INK4-ARF locus
Simboeck, E., Ribeiro, J. D., Teichmann, S., & Croce, L. D. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.084 · Cited by 34
RSK4 inhibition results in bypass of stress-induced and oncogene-induced senescence
López-Vicente, L., Pons, B., Coch, L., Teixidó, C., Hernández‐Losa, J., Armengol, G., & y Cajal, S. R. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr003 · Cited by 32
Induction of p38δ Expression Plays an Essential Role in Oncogenic ras-Induced Senescence
Kwong, J., Chen, M. S., Lv, D., Luo, N., Su, W., Xiang, R., & Sun, P. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00784-13 · Cited by 29
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Mabrouk, N., Ghione, S., Laurens, V., Plenchette, S., Bettaïeb, A., & Paul, C. (2020) · Cancers · doi:10.3390/cancers12051145 · Cited by 31
A Functional Screen for Regulators of CKDN2A Reveals MEOX2 as a Transcriptional Activator of INK4a
Irelan, J. T., del Arroyo, A. G., Gutierrez, A., Peters, G. G., Quon, K. C., Miraglia, L. J., & Chanda, S. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005067 · Cited by 30
Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 31
Resveratrol drives cancer cell senescence via enhancing p38MAPK and DLC1 expressions
Bian, Y., Wang, X., Zheng, Z., Ren, G., Zhu, H., Qiao, M., & Li, G. (2022) · Food & Function · doi:10.1039/d1fo02365a · Cited by 27
Panda, S., Isbatan, A., & Adami, G. R. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.02.014 · Cited by 31
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Tecleab, A., Zhang, X., & Sebti, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565796 · Cited by 32
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Kortlever, R. M., Brummelkamp, T. R., van Meeteren, L. A., Moolenaar, W. H., & Bernards, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0066 · Cited by 29
Oxaloacetate decarboxylase FAHD1 – a new regulator of mitochondrial function and senescence
Etemad, S., Petit, M., Weiss, A. K. H., Schrattenholz, A. S., Baraldo, G., & Jansen‐Dürr, P. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.007 · Cited by 28
Reprogramming cellular senescence and aging clocks for advanced cancer immunotherapy
Yang, H., Liu, D., Qiu, L., Wang, R., Zhang, C., Yu, D., Zhong, Q., Yuki, N., Song, Z., Zhu, Τ., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02459-8 · Cited by 38
ZNF768 links oncogenic RAS to cellular senescence
Villot, R., Poirier, A., Bakan, I., Boulay, K., Fernández, E., Devillers, R., Braga, L. G., Tribouillard, L., Gagné, A., Duchesne, É., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24932-w · Cited by 32
Metadata
- Authors
- Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Medizinische Hochschule Hannover (DE)
- Research Institute of Molecular Pathology (AT)
- Max Delbrück Center (DE)
- Corresponding author
- Schmitt, Clemens A.
- ORCID
- Venue
- Nature
- Published
- 2005-08
- Volume
- 436
- Issue
- 7051
- Pages
- 660-665
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2080769506
- Cited by
- 1,220
- References
- 31
- Citations by year
- 2026: 19 · 2025: 37 · 2024: 34 · 2023: 54 · 2022: 42 · 2021: 57 · 2020: 57 · 2019: 49 · 2018: 49 · 2017: 44 · 2016: 58 · 2015: 53 · 2014: 51 · 2013: 86 · 2012: 69
- FWCI
- 43.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cellular senescence, lymphoma, oncogenic Ras, SUV39H1, H3K9 methylation, heterochromatin, retinoblastoma pathway, p53, T-cell lymphoma, tumor suppression, epigenetic silencing, histone methyltransferase
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lymphoma, Methylation, Methyltransferases, Mice, Transgenic, Precancerous Conditions, Genes, ras, Repressor Proteins, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Disease Progression, Transgenes, ADP-Ribosylation Factors, Chromosomal Instability, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.